JRSA Forum, September 2012, Volume 30, Number 3


Feature Article

Gang Offending and Online Behavior

National Scene

BJS Taps Michael Planty to Head Victimization Statistics Unit

Greg Ridgeway Joins NIJ as Deputy Director


New JRP Issue Focuses on Evidence-Based Policy and Practice

NJJEC Launches Online Program Evaluation Tutorial

Incident-Based Reporting Resource Center Funds New Projects

SAC News

The Arizona Prescription Drug Initiative: A Multisystemic Approach for Targeting Prescription Drug Misuse and Abuse

Georgia, Hawaii, Illinois, Kansas, Massachusetts, Montana, Ohio, Oregon, Tennessee, Vermont, West Virginia, Wisconsin, Wyoming

The JRSA Forum is supported by the U.S. Department of Justice, Bureau of Justice Statistics. JRSA is a national nonprofit organization. For membership or other information, call (202) 842-9330, e-mail cjinfo@jrsa.org, or visit our Web site: http://www.jrsa.org.

Karen F. Maline, Editor
Nancy Michel, Managing Editor


Phillip Stevenson, President
Stephen Haas, Vice President
Carmen Dorsey, Secretary/ Treasurer
Lisa Broidy, Delegate
Lisa Shoaf, Delegate
David Olson, Appointed Delegate
Jackie Vandercook, Past President

Joan C. Weiss, Executive Director

Ali Burnett, Office Manager
Sandra Dayton, Director of Finance and Administration
Shawn Flower, Research Associate
Karen F. Maline, Director of Member Services
Nancy Michel, Director of Publications
Stan Orchowsky, Research Director
Marc Osman, Web Site Manager
Jason Trask, Program Associate
Lisa Walbolt Wagner, Research Associate
Carrie Williamson, Research Associate

JRSA Website - Forum Webpage - Forum PDF - PRINT THIS ARTICLE  

The Arizona Prescription Drug Initiative: A Multisystemic Approach for Targeting Prescription Drug Misuse and Abuse

In November 2011, the Centers for Disease Control and Prevention (CDC) issued a report indicating that deaths from prescription (Rx) pain relievers have reached epidemic proportions in the United States. It is estimated that 40 deaths per day are due to prescription drugs. This exceeds the number of deaths related to heroin and cocaine combined. For the first time in history, drug poisoning has become the number one cause of accidental death in America.

Arizona is not immune from Rx drug misuse and abuse. According to data from Arizona's Prescription Drug Monitoring Program, from 2009 to 2011, there were approximately 10 million Class II-IV prescriptions written each year in Arizona, with Rx pain relievers accounting for more than half of the drugs dispensed (controlled substances are classified into five possible schedules, or classifications, based on the drug's identified potential for abuse and other medical and safety standards- the higher the likelihood of abuse, the lower the schedule class).

As the access to and availability of Rx narcotics grow, so too does the likelihood of misuse and abuse, and, moreover, costly associated outcomes. In 2010, 13% of Arizona adults reported some type of Rx drug misuse in the past 30 days, with half of the misuse related to Rx pain relievers. Likewise, in 2010, 10.4% of Arizona youth reported some type of Rx drug misuse in the past 30 days, with 76.7% of the misuse involving Rx pain relievers. Arizona has also seen a corresponding, and dramatic, increase in opioid-related cases presenting in emergency departments and a similar increase in drug poisoning deaths involving Rx drugs (Arizona Department of Health Services).

Prescription Drug Reduction Initiative
As the single statewide council on substance abuse-related issues, the Arizona Substance Abuse Partnership (ASAP) seeks to ensure community-driven, agency-supported outcomes to prevent and reduce the negative impacts of alcohol, tobacco, and other drugs by building and sustaining partnerships. Through coordination and collaboration among its members and their respective agencies and organizations, the ASAP strives to ensure that substance abuse is addressed in a comprehensive and collaborative manner. To address the growing concern over Rx drug misuse and abuse in Arizona and its associated consequences, the ASAP has endorsed a data-driven Prescription Drug Reduction Initiative (Initiative) cochaired by staff of the Arizona Criminal Justice Commission and Arizona's High Intensity Drug Trafficking Area.

Percentage of Class II-IV Pills Prescribed in Arizona by Type, 2011

The Initiative is designed as a pilot project in three Arizona counties. Selection of the geographic areas was based on the following criteria:

  1. The severity of Rx drug misuse, as indicated by prevalence and consequence data.
  2. The willingness of the county to use a data-driven decisionmaking approach and for its efforts to be evaluated.
  3. Capacity for strategy implementation, including evidence of multisystemic work across the three domains (i.e., medical/treatment, law enforcement, and prevention).

With the Initiative a grassroots effort, it was critical for each county to select its own lead agency/point of contact and to engage one or more community prevention coalitions in the work. Counties with coalitions that had demonstrated efficacy in substance use prevention and intervention were considered to be high capacity, and those counties with coalitions that had participating members or committed networks from the three domains (i.e., prevention, law enforcement, and medical) were considered to have the highest capacity.

Based on these factors, Yavapai, Pinal, and Pima counties were selected as pilot sites. The start date for the activities in the three areas are staggered, with the goal of having each successive wave (i.e., county) incorporate lessons learned from the preceding county or counties. The first pilot site, Yavapai County, kicked off the Initiative on July 1, 2012. The pilot counties will act as a learning community in that the three sites will share information about successes, failures, and lessons learned to help one another as the Initiative moves forward.

The following strategies and goals were developed to decrease the misuse and abuse of prescription drugs in Arizona:

Strategy One: Reduce illicit acquisition and diversion of prescription drugs.

  • Goal One: Increase the use of proper disposal methods for prescription drugs.
  • Goal Two: Increase the use of proper storage methods for prescription drugs in the home.
  • Goal Three: Increase the use of the Prescription Drug Monitoring Program (PDMP).
Strategy Two: Educate prescribers and pharmacists about "Rx drug best practices."
  • Goal One: Develop a research-based "best practice" curriculum for prescribers and pharmacists (Rx Narcotics and Benzodiazepines).
  • Goal Two: Implement a recognition/reward system for effective prescribers and pharmacists.
Strategy Three: Enhance Rx drug practice and policies in law enforcement.
  • Goal One: Provide education and training for law enforcement officers.
  • Goal Two: Improve coding structure of data management systems for tracking Rx drug offenses.
Strategy Four: Increase public awareness about the risks of Rx drug misuse.
  • Goal One: Create a sense of urgency in the general public about the risks of Rx drugs.
  • Goal Two: Implement the Rx 360° Adult (Drug Free America, research-based) curriculum to educate parents and other adults about the risks of youth Rx drug misuse.
Strategy Five: Build resilience in children and adults.
  • Goal One: Implement an adapted Rx 360° Adult (Drug Free America, research-based) curriculum to train parents and adults how to teach youth strategies that increase their resilience to Rx drug abuse.
  • Goal Two: Implement the Rx 360° Youth (Drug Free America, research-based for 8th–12th grade students) to teach youth strategies that increase their resilience to Rx drug abuse.

Both process and outcome evaluation measures will be tracked by staff of the Arizona Statistical Analysis Center, housed in the Arizona Criminal Justice Commission, as a means of monitoring success and for determining the feasibility of implementing the Initiative on a statewide basis.